Thymic Stromal Lymphopoietin anticorps

N° du produit ABIN5647286

Cet anticorps anti-Thymic Stromal Lymphopoietin est un anticorps Lapin Polyclonal détectant Thymic Stromal Lymphopoietin dans WB et ELISA (Capture). Adapté pour Humain et Souris.

Aperçu rapide pour Thymic Stromal Lymphopoietin anticorps (ABIN5647286)

Antigène: Thymic Stromal Lymphopoietin (TSLP)

Reactivité: Humain, Souris

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp Thymic Stromal Lymphopoietin est non-conjugé

Application: Western Blotting (WB), ELISA (Capture)

Détail du produit anti-Thymic Stromal Lymphopoietin anticorps

Purification: Antigen affinity purified

Immunogène: Amino acids KVTTNKCLEQVSQLQGLWRRFNRPLLKQQ were used as the immunogen for the TSLP antibody.

Isotype: IgG

Information d'application

Indications d'application: Optimal dilution of the TSLP antibody should be determined by the researcher.\. Western Blot: 0.5-1 μg/mL,ELISA (Capture, human recombinant protein): 0.1-0.5 μg/mL (BSA-free format available)

Restrictions: For Research Use only

Stockage

Buffer: 0.5 mg/mL if reconstituted with 0.2 mL sterile DI water

Stock: -20 °C

Stockage commentaire: After reconstitution, the TSLP antibody can be stored for up to one month at 4°C. For long-term, aliquot and store at -20°C. Avoid repeated freezing and thawing.

Détails sur Thymic Stromal Lymphopoietin

Antigène: Thymic Stromal Lymphopoietin (TSLP)

Autre désignation: TSLP

Sujet: Thymic stromal lymphopoietin, also called TSLP is a protein belonging to the cytokine family. This gene is mapped to 5q22.1. It encodes a hemopoietic cytokine proposed to signal through a heterodimeric receptor complex composed of the thymic stromal lymphopoietin receptor and the IL-7R alpha chain. It mainly impacts myeloid cells and induces the release of T cell-attracting chemokines from monocytes and enhances the maturation of CD11c(+) dendritic cells. The protein promotes T helper type 2(TH2) cell responses that are associated with immunity in various inflammatory diseases, including asthma, allergic inflammation and chronic obstructive pulmonary disease. The protein is therefore considered a potential therapeutic target for the treatment of such diseases.

UniProt: Q969D9